American Well (AMWL)
(Delayed Data from NYSE)
$0.41 USD
+0.02 (3.87%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $0.40 -0.01 (-1.28%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Price, Consensus and EPS Surprise
AMWL 0.41 +0.02(3.87%)
Will AMWL be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for AMWL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMWL
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
AMWL: What are Zacks experts saying now?
Zacks Private Portfolio Services
American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for AMWL
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT), Johnson & Johnson (JNJ) and American Well (AMWL)
Amwell management to meet virtually with Piper Sandler
Amwell management to meet virtually with Piper Sandler
Piper Sandler Remains a Hold on American Well (AMWL)
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference